Inceptive is a molecule structure platform that designs biotechnology software. With a mission to create more accessible medicine, Inceptive scale experiments with RNA molecules to create the next generation of biological software. The company also uses machine learning to develop complex molecule functionality and design techniques. Inceptive was founded by Jakob Uszkoreit and Rhiju Das in 2021 and is headquartered in San Francisco, CA.
Inceptive Nucleics is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Inceptive Nucleics has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.
Inceptive Nucleics is privately held company and is not publicly traded, therefor investing in Inceptive Nucleics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.
To determine the value of your Inceptive Nucleics shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Inceptive Nucleics shares. You can also learn more about how to sell your private shares before getting started.
Yes, you can seek to sell shares in Inceptive Nucleics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 9/20/2023 | Series A |
$100MM raised | $XXX.XX | $XXX.XX |
| 1/1/2022 | Series Seed-1 and Seed-2 |
$20MM raised | $XXX.XX | $XXX.XX |
